Last reviewed · How we verify

NCT04632147

The Effect of Pranayamic Techniques on Obstructive Sleep Apnea Syndrome

Status unknown NA Last updated 16 September 2021
What this trial tests

NA trial testing Ujjayi pranayama, Nadi-Shodhana pranayama, Sukha pranayama in Obstructive Sleep Apnea Syndrome in 34 participants. Status unknown.

Timeline
20 April 2021
Primary endpoint
20 September 2021
25 September 2021

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment34
Start date20 April 2021
Primary completion20 September 2021
Estimated completion25 September 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 20 to 60, any sex, with Obstructive Sleep Apnea Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study was planned to investigate the effect of pranayama on dyspnea, daytime sleepiness, cognitive function, quality of life, activities of daily living, functional exercise capacity, physical activity level, sleep quality, fatigue, musculoskeletal pain, depression and anxiety in OSAS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The impact of home-based telerehabilitation pranayama on sleep quality and wellbeing in mild to moderate obstructive sleep apnea syndrome. A randomized controlled trial.
    Kaçar Akkoç Z, Demir R, Mustafaoğlu R, Önder ÖÖ, et al · · 2026 · PMID 41992331 · DOI 10.1186/s13030-026-00359-x

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea Syndrome

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04632147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing